The global vaccine contract manufacturing market was worth $1.9bn in 2018 and is expected to grow at a CAGR of 9.3% from 2019-2023. In 2018, the paediatric vaccines segment held 48% of the global vaccine contract manufacturing market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 80 tables and 57 figures– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Download Free Sample Pages of this report

Report Scope

Revenue and growth forecasts from 2019 to 2029 for the global vaccine market

Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market

Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by type:

  • Paediatric Vaccines
  • Adult Vaccines
  • Influenza Vaccines
  • Therapeutic Vaccines

Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by workflow:

  • Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
  • Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:

  • North America: the revenues are further broken down into the US and Canada
  • Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
  • Asia-Pacific: the revenues are further broken down into China, Japan and India
  • Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

The regional markets are further broken down by type and workflow.

Discussion and profiles of the leading players in the vaccine contract manufacturing market:

  • AbbVie
  • Baxter BioPharma Solutions
  • Boehringer Ingelheim
  • Catalent
  • Charles River Laboratories
  • Evonik Degusa
  • IDT Biologika
  • Lonza
  • Meridian Life Science
  • Nipro Corporation
  • Pfizer CentreOne
  • Sigma Aldrich Fine Chemicals
  • SynCo Bio Partners
  • Vetter Pharmaceutical